Update on the management of diabetic polyneuropathies

References

• Vinik AI Mitchell BD Leichter SB Wagner AL O’Brian JT Georges LP Epidemiology of the complications of diabetes Diabetes: Clinical Science in Practice Leslie RDG Robbins DC Cambridge, UK Cambridge University Press 1995 221 287
   Google Scholar
• American Diabetes Association American Academy of Neurology: Report and recommendations of the San Antonio conference on diabetic neuropathy Diabetes Care 1988 11 592 597 3060328
   PubMed Web of Science ®Google Scholar
• Toeller M Buyken AE Heitkamp G Prevalence of chronic complications, metabolic control and nutritional intake in type 1 diabetes: comparison between different European regions. EURODIAB Complications Study group Horm Metab Res 1999 31 680 685 10668922
   PubMed Web of Science ®Google Scholar
• Pirart J Diabetes mellitus and its degenerative complication: a prospective study of 4,400 patients observed between 1947 and 1973 Diabetes Care 1978 1 168 188
   Google Scholar
• Young MJ Boulton AJ MacLeod AF Williams DR Sonksen PH A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population Diabetologia 1993 36 150 154 8458529
   PubMed Web of Science ®Google Scholar
• Lehtinen JM Niskanen L Hyvonen K Siitonen O Uusitupa M Nerve function and its determinants in patients with newly-diagnosed type 2 (non-insulin dependent) diabetes mellitus and in control subjects – a 5-year follow-up Diabetologia 1993 36 68 72 8436256
   PubMed Web of Science ®Google Scholar
• Sumner CJ Sheth S Griffin JW Cornblath DR Polydefkis M The spectrum of neuropathy in diabetes and impaired glucose tolerance Neurology 2003 60 108 111 12525727
   PubMed Web of Science ®Google Scholar
• Ziegler D Rathmann W Dickhaus T Meisinger C Mielck A KORA Study Group Neuropathic pain in diabetes, prediabetes and normal glucose tolerance. The MONICA/KORA Augsburg Surveys S2 and S3 Pain Med 2009 10 393 400 19207236
   PubMed Web of Science ®Google Scholar
• Partanen J Niskanen L Lehtinen J Natural history of peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus N Engl J Med 1995 333 89 94 7777034
   PubMed Web of Science ®Google Scholar
• Ziegler D Gries FA Spuler M Lessmann F The epidemiology of diabetic neuropathy. Diabetic Cardiovascular Autonomic Neuropathy Multicenter Study Group J Diabetes Comp 1992 6 49 57
   PubMedGoogle Scholar
• Tesfaye S Chaturvedi N Eaton SE EURODIAB Prospective Complications Study Group Vascular risk factors and diabetic neuropathy N Engl J Med 2005 352 341 350 15673800
   PubMed Web of Science ®Google Scholar
• Ziegler D Rathmann W Dickhaus T Meisinger C Mielck A for the KORA Study Group Prevalence of polyneuropathy in prediabetes and diabetes is associated with abdominal obesity and macroangiopathy. MONICA/ KORA Augsburg Surveys S2 and S3 Diabetes Care 2008 31 464 469 18039804
   PubMed Web of Science ®Google Scholar
• Thomas PK Classification, differential diagnosis and staging of diabetic peripheral neuropathy Diabetes 1997 46 Suppl 2 S54 S57 9285500
   PubMed Web of Science ®Google Scholar
• Thomas PK Classification of the diabetic neuropathies Gries FA Cameron NE Low PA Ziegler D Textbook of Diabetic Neuropathy Stuttgart, Germany Thieme 2003 175 177
   Google Scholar
• Boulton AJM Malik RA Arezzo JC Sosenko JM Diabetic somatic neuropathies Diabetes Care 2004 27 1458 1486 15161806
   PubMed Web of Science ®Google Scholar
• Boulton AJ Vinik AI Arezzo JC Diabetic neuropathies: a statement by the American Diabetes Association Diabetes Care 2005 28 956 962 15793206
   PubMed Web of Science ®Google Scholar
• Tesfaye S Boulton AJ Dyck PJ Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments Diabetes Care 2010 33 2285 2293 20876709
   PubMed Web of Science ®Google Scholar
• Galer BS Gianas A Jensen MP Painful diabetic neuropathy: epidemiology, pain description, and quality of life Diabetes Res Clin Pract 2000 47 123 128 10670912
   PubMed Web of Science ®Google Scholar
• Sinnreich M Taylor BV Dyck PJ Diabetic neuropathies. Classification, clinical features, and pathophysiological basis Neurologist 2005 11 63 79 15733329
   PubMed Web of Science ®Google Scholar
• Vinik A Ullal J Parson HK Casellini CM Diabetic neuropathies: clinical manifestations and current treatment options Nat Clin Pract Endocrinol Metab 2006 2 269 281 16932298
   PubMedGoogle Scholar
• Cavanagh PR Simoneau GG Ulbrecht JS Ulceration, unsteadiness, and uncertainty: the biomechanical consequences of diabetes mellitus J Biomech 1993 26 Suppl 1 23 40 8505350
   PubMed Web of Science ®Google Scholar
• Katoulis EC Ebdon-Parry M Lanshammar H Vileikyte L Kulkarni J Boulton AJ Gait abnormalities in diabetic neuropathy Diabetes Care 1997 20 1904 1907 9405916
   PubMed Web of Science ®Google Scholar
• Archer AG Watkins PJ Thomas PK Sharma AK Payan J The natural history of acute painful neuropathy in diabetes mellitus J Neurol Neurosurg Psychiatry 1983 46 491 499 6875582
   PubMed Web of Science ®Google Scholar
• Tesfaye S Chaturvedi N Eaton SE Vascular risk factors and diabetic neuropathy N Engl J Med 2005 352 341 350 15673800
   PubMed Web of Science ®Google Scholar
• Steele JM Young RJ Lloyd GG Clarke BF Clinically apparent eating disorders in young diabetic women: associations with painful neuropathy and other complications BMJ 1987 294 859 866 3105777
   PubMed Web of Science ®Google Scholar
• Dabby R Sadeh M Lampl Y Gilad R Watemberg N Acute painful neuropathy induced by rapid correction of serum glucose levels in diabetic patients Biomed Pharmacother 2009 63 707 709 18848759
   PubMed Web of Science ®Google Scholar
• Gemignani F Acute painful diabetic neuropathy induced by strict glycemic control (“insulin neuritis”): the old enigma is still unsolved Biomed Pharm 2009 63 249 250
   Web of Science ®Google Scholar
• Gorson KC Herrmann DN Thiagarajan R Non-length dependent small fibre neuropathy/ganglionopathy J Neurol Neurosurg Psych 2008 79 163 169
   PubMed Web of Science ®Google Scholar
• Stevens MJ Pop-Busui R Holmes C Can I prevent problems in the at risk diabetic foot? Clinical Challenges in Diabetes Barnett A Oxford UK Clinical Publishing Services 2008
   Google Scholar
• Tentolouris N Marinou K Kokotis P Karanti A Diakoumopoulou E Katsilambros N Sudomotor dysfunction is associated with foot ulceration in diabetes Diabet Med 2009 26 302 305 19317826
   PubMed Web of Science ®Google Scholar
• Liatis S Marinou K Tentolouris N Pagoni S Katsilambros N Usefulness of a new indicator test for the diagnosis of peripheral and autonomic neuropathy in patients with diabetes mellitus Diabet Med 2007 24 1375 1380 17941862
   PubMed Web of Science ®Google Scholar
• McArthur JC Stocks EA Hauer P Cornblath DR Griffin JW Epidermal nerve fiber density: normative reference range and diagnostic efficiency Arch Neurol 1998 55 1513 1520 9865794
   PubMed Web of Science ®Google Scholar
• Goransson LG Mellgren SI Lindal S Omdal R The effect of age and gender on epidermal nerve fiber density Neurology 2004 62 774 777 15007129
   PubMed Web of Science ®Google Scholar
• Quattrini C Tavakoli M Jeziorska M Surrogate markers of small fiber damage in human diabetic neuropathy Diabetes 2007 56 2148 2154 17513704
   PubMed Web of Science ®Google Scholar
• Kennedy WR Wendelschafer-Crabb G Johnson T Quantitation of epidermal nerves in diabetic neuropathy Neurology 1996 47 1042 1048 8857742
   PubMed Web of Science ®Google Scholar
• Herrmann DN Griffin JW Hauer P Cornblath DR McArthur JC Epidermal nerve fiber density and sural nerve morphometry in peripheral neuropathies Neurology 1999 53 1634 1640 10563605
   PubMed Web of Science ®Google Scholar
• Shun CT Chang YC Wu HP Skin denervation in type 2 diabetes: correlations with diabetic duration and functional impairments Brain 2004 127 1593 1605 15128619
   PubMed Web of Science ®Google Scholar
• Pittenger GL Ray M Burcus NI McNulty P Basta B Vinik AI Intraepidermal nerves are indicators of small-fiber neuropathy in both diabetic and nondiabetic patients Diabetes Care 2004 27 1974 1979 15277426
   PubMed Web of Science ®Google Scholar
• Mehra S Tavakoli M Kallinikos PA Corneal confocal microscopy detects early nerve regeneration after pancreas transplantation in patients with type 1 diabetes Diabetes Care 2007 30 2608 2612 17623821
   PubMed Web of Science ®Google Scholar
• Dyck PJB Norell JE Dyck PJ Microvasculitis and ischemia in diabetic lumbosacral radiculoplexus neuropathy Neurology 1999 53 2113 2121 10599791
   PubMed Web of Science ®Google Scholar
• Llewelyn JG Thomas PK King RHM Epineurial microvasculitis in proximal diabetic neuropathy J Neurol 1998 245 159 165 9553846
   PubMed Web of Science ®Google Scholar
• Kelkar PM Masood M Parry GJ Distinctive pathologic findings in proximal diabetic neuropathy (diabetic amyotrophy) Neurology 2000 55 83 88 10891910
   PubMed Web of Science ®Google Scholar
• Vinik A Mehrabyan A Colen L Boulton A Focal entrapment neuropathies in diabetes Diabetes Care 2004 27 1783 1788 15220266
   PubMed Web of Science ®Google Scholar
• Garland H Diabetic amyotrophy Br J Clin Pract 1961 15 9 13 13703676
   PubMedGoogle Scholar
• Asbury AK Proximal diabetic neuropathy Ann Neurol 1977 2 179 180 617563
   PubMed Web of Science ®Google Scholar
• Chokroverty S Reyes MG Rubino FA The syndrome of diabetic amyotrophy Ann Neurol 1977 2 131
   Web of Science ®Google Scholar
• Brownlee M Biochemistry and molecular cell biology of diabetic complications Nature 2001 414 813 820 11742414
   PubMed Web of Science ®Google Scholar
• Singh R Barden A Mori T Beilin L Advanced glycation end products: a review Diabetologia 2001 44 129 146 11270668
   PubMed Web of Science ®Google Scholar
• Friedman EA Advanced glycosylated end products and hyperglycemia in the pathogenesis of diabetic complications Diabetes Care 1999 22 Suppl 2 B65 B71 10097902
   PubMed Web of Science ®Google Scholar
• Charonis AS Reger LA Dege JE Laminin alterations after in vitro nonenzymatic glycosylation Diabetes 1990 39 807 814 2113013
   PubMed Web of Science ®Google Scholar
• Abordo EA Thornalley PJ Synthesis and secretion of tumour necrosis factor-alpha by human monocytic THP-1 cells and chemotaxis induced by human serum albumin derivatives modified with methylglyoxal and glucose-derived advanced glycation endproducts Immunol Lett 1997 58 139 147 9293394
   PubMed Web of Science ®Google Scholar
• Kirstein M Aston C Hintz R Vlassara H Receptor-specific induction of insulin-like growth factor I in human monocytes by advanced glycosylation end product-modified proteins J Clin Invest 1992 90 2 439 446 1322940
   PubMed Web of Science ®Google Scholar
• Schmidt AM Hori O Chen JX Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes J Clin Invest 1995 96 1395 1403 7544803
   PubMed Web of Science ®Google Scholar
• Brownlee M The pathobiology of diabetic complications Diabetes 2005 54 1615 1625 15919781
   PubMed Web of Science ®Google Scholar
• King GL Brownlee M The cellular and molecular mechanisms of diabetic complications Endocrinol Metab Clin North Am 1996 25 255 270 8799700
   PubMed Web of Science ®Google Scholar
• Meier M King GL Protein kinase C activation and its pharmacological inhibition in vascular disease Vasc Med 2000 5 173 185 11104300
   PubMed Web of Science ®Google Scholar
• Figueroa-Romero C Sadidi M Feldman EL Mechanisms of disease: the oxidative stress theory of diabetic neuropathy Rev End Metab Dis 2008 9 301 314
   PubMed Web of Science ®Google Scholar
• Baynes JW Thorpe SR Role of oxidative stress in diabetic complications: a new perspective on an old paradigm Diabetes 1999 48 1 9 9892215
   PubMed Web of Science ®Google Scholar
• Nishikawa T Kukidome D Sonoda K Impact of mitochondrial ROS production on diabetic vascular complications Diabetes Res Clin Pract 2007 77 3 Suppl 1 S41 S45 17452060
   PubMed Web of Science ®Google Scholar
• Bucala R Tracey KJ Cerami A Advance glycation products quench nitric oxide and mediate endohelium dependent vasodilatation in experimental diabetes J Clin Invest 1991 87 432 438 1991829
   PubMed Web of Science ®Google Scholar
• Hawthorne GC Bartlett K Hetherington CS Albertic KG The effects of high glucose on polyol pathway activity in cultured human endothelial cells Diabetologia 1989 32 196 199
   Web of Science ®Google Scholar
• Wolf BA Willianson JR Easan RA Diacylglycerol accumulation and microvascular abnormalities induced by elevated blood glucose levels J Clin Invest 1991 87 31 38 1985103
   PubMed Web of Science ®Google Scholar
• Vinik AI Erbas T Park TS Stansberry KB Scanelli JA Pittenger GL Dermal neurovascular dysfunction in type 2 diabetes Diabetes Care 2001 24 1468 1475 11473088
   PubMed Web of Science ®Google Scholar
• Obrosova IG Drel VR Pacher P Oxidative-nitrosative stress and poly(ADP-ribose) polymerase (PARP) activation in experimental diabetic neuropathy Diabetes 2005 54 3435 3441 16306359
   PubMed Web of Science ®Google Scholar
• Baron R Mechanisms of disease: neuropathic pain – a clincal perspective Nature Clin Pract Neurol 2006 2 95 106 16932531
   PubMedGoogle Scholar
• Lai J Hunter JC Porreca F The role of voltage-gated sodium channels in neuropathic pain Curr Opin Neurobiol 2003 13 291 297 12850213
   PubMed Web of Science ®Google Scholar
• Wood JN Boorman JP Okuse K Baker MD Voltage-gated sodium channels and pain pathways J Neurobiol 2004 61 55 71 15362153
   PubMedGoogle Scholar
• Loeser JD CRPS: Current Diagnosis and Therapy, Progress in Pain Research and Management Introduction by JD Loeser Seattle IASP Press Wilson PR Stanton-Hicks M Harden RN 2005 32 3 7
   Google Scholar
• Sorensen L Molyneaux L Yue DK The relationship among pain, sensory loss, and small nerve fibers in diabetes Diabetes Care 2006 29 883 887 16567832
   PubMed Web of Science ®Google Scholar
• Treede RD Jensen TS Campbell JN Redefinition of neuropathic pain and a grading system for clinical use: consensus statement on clinical and research diagnostic criteria Neurology 2008 70 1630 1635 18003941
   PubMed Web of Science ®Google Scholar
• DCCT Research Group The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin dependent diabetes mellitus N Engl J Med 1993 329 977 986 8366922
   PubMed Web of Science ®Google Scholar
• DCCT Research Group The effect of intensive diabetes therapy on the development and progression of neuropathy Ann Intern Med 1995 122 561 568 7887548
   PubMed Web of Science ®Google Scholar
• Albers JW Herman WH Pop-Busui R Effect of prior intensive insulin treatment during the diabetes control and complications trial (DCCT) on peripheral neuropathy in type 1 diabetes during the epidemiology of diabetes interventions and complications (EDIC) study Diabetes Care 2010 33 1090 1096 20150297
   PubMed Web of Science ®Google Scholar
• Oyibo SO Prasad YD Jackson NJ Jude EB Boulton AJ The relationship between blood glucose excursions and painful diabetic peripheral neuropathy: a pilot study Diabet Med 2002 19 870 873 12358878
   PubMed Web of Science ®Google Scholar
• Boulton AJ Drury J Clarke B Ward JD Continuous subcutaneous insulin infusion in the management of painful diabetic neuropathy Diabetes Care 1982 5 386 390 7151654
   PubMed Web of Science ®Google Scholar
• UK Prospective Diabetes Study Group Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 BMJ 1998 317 703 713 Erratum in BMJ 1999; 318(7175):29 9732337
   PubMed Web of Science ®Google Scholar
• UK Prospective Diabetes Study (UKPDS) Group Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) Lancet 1998 352 854 865 9742977
   PubMed Web of Science ®Google Scholar
• Gaede P Vedel P Larsen N Jensen G Parving H Pedersen O Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes N Engl J Med 2003 384 383 393 12556541
   PubMed Web of Science ®Google Scholar
• Ruhnau KJ Meissner HP Finn R Effects of 3-week oral treatment with the antioxidant thioctic acid (alpha-lipoic acid) in symptomatic diabetic polyneuropathy Diabet Med 1999 16 1040 1043 10656234
   PubMed Web of Science ®Google Scholar
• Ziegler D Nowak H Kempler P Vargha P Low PA Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a meta-analysis Diabet Med 2004 21 114 121 14984445
   PubMed Web of Science ®Google Scholar
• Ziegler D Hanefeld M Ruhnau KJ Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN Study) Diabetologia 1995 38 1425 1433 8786016
   PubMed Web of Science ®Google Scholar
• Reljanovic M Reichel G Rett K Treatment of diabetic polyneuropathy with the antioxidant thioctic acid (alpha-lipoic acid): a two year multicenter randomized double-blind placebo-controlled trial (ALADIN II). Alpha Lipoic Acid in Diabetic Neuropathy Free Radic Res 1999 31 171 179 10499773
   PubMed Web of Science ®Google Scholar
• Ametov AS Barinov A Dyck PJ The sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoic acid: the SYDNEY trial Diabetes Care 2003 26 770 776 12610036
   PubMed Web of Science ®Google Scholar
• Ziegler D Ametov A Barinov A Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial Diabetes Care 2006 29 2365 2370 17065669
   PubMed Web of Science ®Google Scholar
• Ziegler D Low PA Boulton AJ Effect of 4-year antioxidant treatment with alpha-lipoic acid in diabetic polyneuropathy: The NATHAN 1 Trial [abstract] Diabetes 2007 56 A2
   Web of Science ®Google Scholar
• Vinik A Bril V Kempler P MBBQ Study Treatment of symptomatic diabetic peripheral neuropathy with protein kinase CB inhibitor ruboxistaurin mesylate during a 1-year randomized, placebo-controlled, double-blind clinical trial Clin Ther 2005 27 1164 1180s 16199243
   PubMed Web of Science ®Google Scholar
• Vinik AI Bril V Litchy WJ Price KL Bastyr EJIII Sural sensory action potential identifies diabetic peripheral neuropathy responders to therapy Muscle Nerve 2005 32 619 625 16116628
   PubMed Web of Science ®Google Scholar
• Hotta N Toyota T Matsuoka K Clinical efficacy of fidarestat, a novel aldose reductase inhibitor, for diabetic peripheral neuropathy Diabetes Care 2001 24 1776 1782 11574441
   PubMed Web of Science ®Google Scholar
• Hotta N Shigeta Y Sakamoto N Long-term effects of epalrestat, an aldose reductase inhibitor, on diabetic peripheral neuropathy: a 3-y multicenter comparative study, ARI-Diabetes Complications Trial (ADCT) [abstract] Diabetes 2005 54 A213
   Web of Science ®Google Scholar
• Bril V Hirose T Tomioka S Buchanan R Ranirestat for the management of diabetic sensorimotor polyneuropathy Diabetes Care 2009 32 1256 1260 19366965
   PubMed Web of Science ®Google Scholar
• Miyauchi Y Shikama H Takasu T Slowing of peripheral motor nerve conduction was ameliorated by aminoguanidine in streptozocin-induced diabetic rats Eur J Endocrinol 1996 134 467 473 8640299
   PubMed Web of Science ®Google Scholar
• Haupt E Ledermann H Kopcke W Benfotiamine in the treatment of diabetic polyneuropathy – a three-week randomized, controlled pilot study (BEDIP study) Int J Clin Pharmacol Ther 2005 43 71 77 15726875
   PubMed Web of Science ®Google Scholar
• Stracke H Lindemann A Federlin K A benfotiamine-vitamin B combination in treatment of diabetic polyneuropathy Exp Clin Endocrinol Diabetes 1996 104 311 316 8886748
   PubMed Web of Science ®Google Scholar
• Pittenger G Vinik A Nerve growth factor and diabetic neuropathy Exp Diabesity Res 2003 4 271 285 14668049
   PubMedGoogle Scholar
• Vinik A Treatment of diabetic polyneuropathy (DPN) with recombinant human nerve growth factor (rhNGF) [abstract] Diabetes 1999 48 Suppl 1 A54 A55
   Google Scholar
• Chattopadhyay M Krisky D Wolfe D Glorioso JC Mata M Fink DJ HSV-mediated gene transfer of vascular endothelial growth factor to dorsal root ganglia prevents diabetic neuropathy Gene Therapy 2005 12 1377 1384 15843809
   PubMed Web of Science ®Google Scholar
• Ropper AH Gorson KC Gooch CL Vascular endothelial growth factor gene transfer for diabetic polyneuropathy: a randomized, double-blinded trial Ann Neurol 2009 65 386 393 19399887
   PubMed Web of Science ®Google Scholar
• Tam J Rosenberg L Maysinger D INGAP peptide improves nerve function and enhances regeneration in streptozotocin-induced diabetic C57BL/6 mice FASEB J 2004 18 1767 1769 15345684
   PubMed Web of Science ®Google Scholar
• Stevens MJ Li F Drel VR Nicotinamide reverses neurological and neurovascular deficits in streptozotocin-diabetic rats J Pharm Exp Ther 2007 320 458 464
   PubMed Web of Science ®Google Scholar
• Malik RA Williamson S Abbott C Effect of angiotensin-converting-enzyme (ACE) inhibitor trandolapril on human diabetic neuropathy: randomised double-blind controlled trial Lancet 1998 352 19
   Web of Science ®Google Scholar
• Ziegler D Painful diabetic neuropathy Diabetes Care 2009 32 Suppl 2 S414 S419 19875591
   PubMed Web of Science ®Google Scholar
• Max M Lynch S Muir J Effects of desipramine, amitryptiline and fluoxetine on pain in diabetic neuropathy N Engl J Med 1992 326 1250 1256 1560801
   PubMed Web of Science ®Google Scholar
• Ray WA Meredith S Thapa PB Cyclic antidepressants and the risk of sudden cardiac death Clin Pharmacol Ther 2004 75 234 241 15001975
   PubMed Web of Science ®Google Scholar
• Sindrup S Gram L Brosen K The selective serotonin reuptake inhibitor paroxetine is effective in treatment of diabetic neuropathy symptoms Pain 1990 42 135 144 2147235
   PubMed Web of Science ®Google Scholar
• Finnerup NB Otto M McQuay HJ Algorithm for neuropathic pain treatment: an evidence based proposal Pain 2005 118 289 305 16213659
   PubMed Web of Science ®Google Scholar
• Tesfaye S Selvarajah D Recent advances in the pharmacological management of painful diabetic neuropathy Br J Diabetes Vasc Dis 2009 9 283 287
   Google Scholar
• Raskin J Wang F Pritchett YL Goldstein DJ Duloxetine for patients with diabetic peripheral neuropathic pain: a 6-month open-label safety study Pain Med 2006 7 373 385 17014595
   PubMed Web of Science ®Google Scholar
• Goldstein DJ Lu Y Detke MJ Duloxetine vs placebo in patients with painful diabetic neuropathy Pain 2005 116 109 118 15927394
   PubMed Web of Science ®Google Scholar
• Raskin J Pritchett YL Wang F A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain Pain Med 2005 6 346 356 16266355
   PubMed Web of Science ®Google Scholar
• Wernicke JF Pritchett YL D’Souza DN A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain Neurology 2006 67 1411 1420 17060567
   PubMed Web of Science ®Google Scholar
• [No authors listed] Duloxetine (Cymbalta) for diabetic neuropathic pain Med Lett Drugs Ther 2005 47 67 16103866
   PubMed Web of Science ®Google Scholar
• Hardy T Sachson R Shen S Does treatment with duloxetine for neuropathic pain impact glycemic control? Diabetes Care 2007 30 21 26 17192327
   PubMed Web of Science ®Google Scholar
• Rowbotham MC Goli V Kunz NR Lei D Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study Pain 2004 110 697 706 15288411
   PubMed Web of Science ®Google Scholar
• Vinik A Advances in diabetes for the millennium: new treatments for diabetic neuropathies Med Gen Med 2004 6 3 Suppl 13
   Google Scholar
• Vinik A Use of antiepileptic drugs in the treatment of chronic painful diabetic neuropathy J Clin Endocrinol Metab 2005 90 4936 4945 15899953
   PubMed Web of Science ®Google Scholar
• Backonja M Beydoun A Edwards KR Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus. A randomized controlled trial JAMA 1998 280 1831 9846777
   PubMed Web of Science ®Google Scholar
• Morello CM Leckband SG Stoner CP Randomized double-blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain Arch Intern Med 1999 159 1931 10493324
   PubMed Web of Science ®Google Scholar
• Rowbotham M Harden N Stacey B Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial JAMA 1998 280 1837 1842 9846778
   PubMed Web of Science ®Google Scholar
• Bryans JS Wustrow DJ 3-substituted GABA analogs with central nervous system activity: a review Med Res Rev 1999 19 149 177 10189176
   PubMed Web of Science ®Google Scholar
• Dooley DJ Mieske CA Borosky SA Inhibition of K(+)-evoked glutamate release from rat neocortical and hippocampal slices by gabapentin Neurosci Lett 2000 280 107 10686389
   PubMed Web of Science ®Google Scholar
• Fehrenbacher JC Taylor CP Vasko MR Pregabalin and gabapentin reduce release of substance P and CGRP from rat spinal tissues only after inflammation or activation of protein kinase C Pain 2003 105 133 141 14499429
   PubMed Web of Science ®Google Scholar
• Freeman R Durso-Decruz E Emir B Efficacy, safety, and tolerability of pregabalin treatment for painful diabetic peripheral neuropathy: findings from seven randomized, controlled trials across a range of doses Diabetes Care 2008 31 1448 1454 18356405
   PubMed Web of Science ®Google Scholar
• Frampton JE Scott LJ Pregabalin: in the treatment of painful diabetic peripheral neuropathy Drugs 2004 64 2813 2820 15563250
   PubMed Web of Science ®Google Scholar
• Eisenberg E Lurie Y Braker C Lamotrigine reduces painful diabetic neuropathy: a randomized, controlled study Neurology 2001 57 505 509 11502921
   PubMed Web of Science ®Google Scholar
• Rull JA Quibrera R Gonzalez-Millan H Lozano CO Symptomatic treatment of peripheral diabetic neuropathy with carbamazepine (Tegretol): double blind crossover trial Diabetologia 1969 5 215 218 4902717
   PubMed Web of Science ®Google Scholar
• McQuay H Carroll D Jadad AR Anticonvulsant drugs for management of pain: a systematic review BMJ 1995 311 1047 1052 7580659
   PubMed Web of Science ®Google Scholar
• Raskin P Donofrio PD Rosenthal NR Topiramate vs placebo in painful diabetic neuropathy: analgesic and metabolic effects Neurology 2004 63 865 873 15365138
   PubMed Web of Science ®Google Scholar
• Thienel U Neto W Schwabe SK Vijapurkar U Topiramate Diabetic Neuropathic Pain Study Group. Topiramate in painful diabetic polyneuropathy: findings from three double-blind placebo-controlled trials Acta Neurol Scand 2004 110 221 231 15355485
   PubMed Web of Science ®Google Scholar
• Shaibani A Fares S Selam JL Lacosamide in painful diabetic neuropathy: an 18-week double-blind placebo-controlled trial J Pain 2009 10 818 828 19409861
   PubMed Web of Science ®Google Scholar
• Wymer JP Simpson J Sen D Bongardt S Efficacy and safety of lacosamide in diabetic neuropathic pain: an 18-week double-blind placebo-controlled trial of fixed-doseregimens Clin J Pain 2009 25 376 385 19454870
   PubMed Web of Science ®Google Scholar
• Ziegler D Hidvegi T Gurieva I Efficacy and safety of lacosamide in painful diabetic neuropathy Diabetes Care 2010 33 839 841 20067958
   PubMed Web of Science ®Google Scholar
• Mason L Moore RA Derry S Edwards JE McQuay HJ Systematic review of topical capsaicin for the treatment of chronic pain BMJ 2004 328 991 15033881
   PubMed Web of Science ®Google Scholar
• Nolano M Simone DA Wendelschafer-Crabb G Johnson T Hazen E Kennedy WR Topical capsaicin in humans: parallel loss of epidermal nerve fibers and pain sensation Pain 1999 81 135 145 10353501
   PubMed Web of Science ®Google Scholar
• Barbano RL Herrmann DN Hart-Gouleau S Effectiveness, tolerability, and impact on quality of life of the 5% lidocaine patch in diabetic polyneuropathy Arch Neurol 2004 61 914 918 15210530
   PubMed Web of Science ®Google Scholar
• Baron R Mayoral V Leijon G 5% lidocaine medicated plaster versus pregabalin in post-herpetic neuralgia and diabetic polyneuropathy: an open-label, non-inferiority two-stage RCT study Curr Med Res Opin 2009 25 1663 1676 19485723
   PubMed Web of Science ®Google Scholar
• Baron R Mayoral V Leijon G 5% lidocaine medicated plaster versus pregabalin in post-herpetic neuralgia and diabetic polyneuropathy: an open-label, non-inferiority two-stage RCT study Curr Med Res Opin 2009 25 1663 1676 19485723
   PubMed Web of Science ®Google Scholar
• Harati Y Gooch C Swenson M Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy Neurology 1998 50 1842 1846 9633738
   PubMed Web of Science ®Google Scholar
• Watson CP Moulin D Watt-Watson J Controlled-release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy Pain 2003 105 71 78 14499422
   PubMed Web of Science ®Google Scholar
• Gimbel JS Richards P Portenoy RK Controlled-release oxycodone for pain in diabetic neuropathy: a randomized controlled trial Neurology 2003 60 927 934 12654955
   PubMed Web of Science ®Google Scholar
• Yuen KC Baker NR Rayman G Treatment of chronic painful diabetic neuropathy with isosorbide dinitrate spray: a double-blind placebo-controlled cross-over study Diabetes Care 2002 25 1699 1704 12351464
   PubMed Web of Science ®Google Scholar
• Rayman G Baker NR Krishnan ST Glyceryl trinitrate patches as an alternative to isosorbide dinitrate spray in the treatment of chronic painful diabetic neuropathy Diabetes Care 2003 26 2697 2698 12941745
   PubMed Web of Science ®Google Scholar
• Pharmaprojects; 2010. Pharma R&D annual review 2010. Available at: www.pharmaprojects.com. Accessed 15 May 2011
   Google Scholar
• Li F Abatan OI Kim H Taurine reverses neurological and neurovascular deficits in Zucker diabetic fatty rats Neurobiol Dis 2006 22 669 676 16624563
   PubMed Web of Science ®Google Scholar
• Quatraro A Roca P Donzella C Acetyl-L-carnitine for symptomatic diabetic neuropathy Diabetologia 1995 38 123 7744218
   PubMed Web of Science ®Google Scholar
• Sima AA Calvani M Mehra M Amato A Acetyl-L-carnitine improves pain, nerve regeneration, and vibratory perception in patients with chronic diabetic neuropathy: an analysis of two randomized placebo-controlled trials Diabetes Care 2005 28 89 94 15616239
   PubMed Web of Science ®Google Scholar
• Cohen KL Harris S Efficacy and safety of nonsteroidal anti-inflammatory drugs in the therapy of diabetic neuropathy Arch Intern Med 1987 147 1442 1444 3115210
   PubMed Web of Science ®Google Scholar
• Dellon AL Treatment of symptomatic diabetic neuropathy by surgical decompression of multiple peripheral nerves Plast Reconstr Surg 1992 89 689 692 1546082
   PubMed Web of Science ®Google Scholar